Distribution pattern of matrix metalloproteinases 1, 2, 3, and 9, tissue inhibitors of matrix metalloproteinases 1 and 2, and α2-macroglobulin in cases of generalized AA- and AL amyloidosis

Virchows Archiv

Volumn 437, Issue 5, 2000, Pages 521-527

  Muller D ^a   Roessner, A ^a   Rocken C ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Amyloid; Matrix metalloproteinases; Protease; Protease inhibitors

Indexed keywords

ALPHA 2 MACROGLOBULIN; AMYLOID; AMYLOID A PROTEIN; COLLAGENASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE INHIBITOR; PROTEINASE; PROTEINASE INHIBITOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; AUTOPSY; BASEMENT MEMBRANE; CLINICAL ARTICLE; CONNECTIVE TISSUE; EXTRACELLULAR MATRIX; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEINASE INHIBITION; RHEUMATOID ARTHRITIS; TUBERCULOSIS;

EID: 0033669024     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280000271     Document Type: Article

References (34)

1. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis
2. High-molecular-mass proteins in haemodialysis-associated amyloidosis
3. Presence of beta-2 microglobulin and alpha-2 macroglobulin in kappa AL-amyloidosis
4. Matrix metalloproteinases in tumour invasion and metastasis
5. Physiological roles of matrix metalloproteinases: Implications for tumor growth and metastasis
6. Amyloid deposits and amyloidosis. The β-fibrilloses
7. Amyloid deposits and amyloidosis. The β-fibrilloses
8. α2-macroglobulin protects some of the protein constituents of dialysis-associated amyloidosis from protease degradation
9. Immunohistochemical classification of 140 autopsy cases with systemic amyloidosis
10. Serum amyloid A (SAA): Biochemistry, genetics and the pathogenesis of AA amyloidosis
11. Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis
12. Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity
13. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinase 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers
14. Classification of amyloid syndromes from tissue sections using antibodies against various amyloid fibril proteins: Report of 142 cases
15. The acute phase response and its relation to amyloid A degrading activity in serum of patients with rheumatoid arthritis undergoing arthroplasty
16. Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts
17. The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin
18. Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland
19. Stromelysins 1 and 2
20. Matrix metalloproteinases
21. On the binding of Congo red by amyloid
22. The classification of amyloid deposits in clinicopathological practice
23. Generalized AA-amyloidosis in a 58-year-old Caucasian woman with an 18-month history of gastrointestinal tuberculosis
24. Rosai-Dorfman disease and generalized AA amyloidosis. A case report
25. Serum MMP-3 in rheumatoid arthritis: Correlation with systemic inflammation but not erosive status
26. Neutrophil proteases associated with amyloid fibrils
27. Diagnosis and immunohistochemical classification of systemic amyloidoses. Report of 43 cases in an unselected autopsy series
28. α2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease
29. Experimental AA amyloidogenesis is associated with differential expression of extracellular matrix genes
30. In vitro degradation of serum amyloid A by cathepsin D and other acid proteases: Possible protection against amyloid fibril formation
31. Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain
32. 72-kDa gelatinase (gelatinase A): Structure, activation, regulation, and substrate specificity
33. Inhibition of α (2)-macroglobulin/proteinase-mediated degradation of amyloid β peptide by apolipoprotein E and α(1)-antichymotrypsin - Evidence that the α (2)- macroglobulin/proteinase complex mediates degradation of the Aβ peptide